You have 9 free searches left this month | for more free features.

liraglutide

Showing 1 - 25 of 281

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Polycystic Ovary Trial in Bani Suwayf (liraglutide, Metformin)

Not yet recruiting
  • Polycystic Ovary
  • Banī Suwayf, Beni Suef, Egypt
    Beni-suef university Hospital
Jul 28, 2023

Obesity, Childhood, Neural Development Trial in New Haven (Liraglutide)

Completed
  • Obesity, Childhood
  • Neural Development
  • Liraglutide
  • New Haven, Connecticut
    Yale University
Dec 5, 2022

Parkinson Disease Trial in Los Angeles (Liraglutide, Placebo)

Completed
  • Parkinson Disease
  • Liraglutide
  • Placebo
  • Los Angeles, California
    Cedars Sinai Medical Center
Oct 27, 2022

Obesity, Status Post Sleeve Gastrectomy Trial run by the NICHD (Liraglutide)

Recruiting
  • Obesity
  • Status Post Sleeve Gastrectomy
  • Liraglutide
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 16, 2022

Diabetes, Type 1 Trial in Monterrey (Liraglutide)

Recruiting
  • Diabetes Mellitus, Type 1
  • Liraglutide
  • Monterrey, Nuevo León, Mexico
    Centro Médico Nacional del Noreste Hospital de Especialidades UM
Jul 19, 2022

Growth Hormone Deficiency, Healthy Trial in New York (growth hormone and lirglutide, growth hormone, liraglutide)

Not yet recruiting
  • Growth Hormone Deficiency
  • Healthy
  • growth hormone and lirglutide
  • +3 more
  • New York, New York
    Neuroendocrine Unit and Pituitary Center, Columbia University Ir
Dec 27, 2022

Obesity Trial in Rochester (Liraglutide, Placebo)

Completed
  • Obesity
  • Liraglutide
  • Placebo
  • Rochester, Minnesota
    Mayo Clinic in Rochester
May 27, 2022

Obese, Overweight Trial in Shanghai (Liraglutide, Placebo)

Active, not recruiting
  • Obese
  • Overweight
  • Liraglutide
  • Placebo
  • Shanghai, China
    Zhongshan Hosital, Fudan University
Apr 16, 2022

Type 2 Diabetes Trial in Chongqing (Liraglutide, Oral antidiabetic drugs: Metformin, Sulfonylureas (2nd generation),

Completed
  • Type 2 Diabetes Mellitus
  • Liraglutide
  • Oral antidiabetic drugs: Metformin, Sulfonylureas (2nd generation), Thiazolidinediones, α-Glucosidase inhibitors, and Glinides
  • Chongqing, Chongqing, China
    The third hospital affiliated to the Third Military Medical Univ
Apr 30, 2022

Type 1 Diabetes Trial in Buffalo (Liraglutide)

Active, not recruiting
  • Type 1 Diabetes
  • Liraglutide
  • Buffalo, New York
    UBMD Pediatrics, Division of Pediatric Endocrinology
Mar 7, 2022

Type 2 Diabetes Trial in Helsinki (Liraglutide, Placebo)

Completed
  • Type 2 Diabetes
  • Liraglutide
  • Placebo
  • Helsinki, Finland
    Helsinki University Central Hospital
Apr 11, 2022

Type 2 Diabetes Treated With Insulin, Obesity, Adolescent Obesity Trial in Lahore (Dulaglutide, Liraglutide)

Completed
  • Type 2 Diabetes Treated With Insulin
  • +2 more
  • Lahore, Punjab, Pakistan
    Zainab Khan
Mar 11, 2022

Diabete Type 2 Trial (Liraglutide, Placebo)

Not yet recruiting
  • Diabete Type 2
  • Liraglutide
  • Placebo
  • (no location specified)
Feb 24, 2022

Bipolar Disorder, Obesity Trial in Mason (LIRAGLUTIDE, Placebo)

Active, not recruiting
  • Bipolar Disorder
  • Obesity
  • LIRAGLUTIDE
  • Placebo
  • Mason, Ohio
    Lindner Center of HOPE
May 24, 2022

Ischemic Stroke, Transient Ischemic Attack, Type 2 Diabetes Trial in Guangzhou (Liraglutide)

Recruiting
  • Ischemic Stroke
  • +2 more
  • Liraglutide
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Jinan University
Mar 17, 2022

Type2 Diabetes Trial in Charlottesville (Exercise, Liraglutide)

Recruiting
  • Type2 Diabetes
  • Exercise
  • Liraglutide
  • Charlottesville, Virginia
    University of Virginia
Mar 7, 2022

Diabetes, Type 2, Hemodialysis, Obese Trial in Paris, Saint-Ouen (Liraglutide)

Recruiting
  • Diabetes Mellitus, Type 2
  • +2 more
  • Liraglutide
  • Paris, Groupe Hospitalier Paris Saint-Joseph, France
  • +3 more
Mar 30, 2022

Healthy Trial in Singapore (LY3537021, Liraglutide, Placebo)

Active, not recruiting
  • Healthy
  • Singapore, Singapore
    Lilly Centre for Clinical Pharmacology
Nov 22, 2022

Type 1 Diabetes Trial in Idaho Falls, Seattle (Liraglutide, Golimumab)

Completed
  • Type 1 Diabetes Mellitus
  • Idaho Falls, Idaho
  • +1 more
Jan 21, 2022

Overweight, Obesity Trial in United States (Semaglutide, Placebo (semaglutide), Liraglutide)

Completed
  • Overweight
  • Obesity
  • Birmingham, Alabama
  • +18 more
Apr 26, 2022

Obesity, Visceral, Cardiovascular Diseases, Fat Disorder Trial in Dallas (Liraglutide, Placebo)

Completed
  • Obesity, Visceral
  • +2 more
  • Liraglutide
  • Placebo
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Oct 20, 2021

Harmonizing RCT-Duplicate Emulations In A Real World Replication

Completed
  • Type 2 Diabetes Mellitus
  • Gothenburg, Sweden
    Research Site
Oct 23, 2023

Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (liraglutide, )

Completed
  • Metabolism and Nutrition Disorder
  • Obesity
  • liraglutide
  • placebo
  • Santa Monica, California
  • +31 more
Nov 18, 2022

Type 2 Diabetes, Mild Cognitive Impairment Trial in Nanjing (Liraglutide, Empagliflozin, Linagliptin)

Recruiting
  • Type 2 Diabetes Mellitus
  • Mild Cognitive Impairment
  • Liraglutide
  • +2 more
  • Nanjing, Jiangsu, China
  • +1 more
Mar 28, 2022

Obesity Trial in Changsha (Liraglutide, Liraglutide;metformin)

Withdrawn
  • Obesity
  • Changsha, Hunan, China
    Xiangya Hospital of Central South University
Apr 8, 2021